PHARMACY

Rite Aid discounts flu shots in support of National Influenza Vaccination Week

BY Michael Johnsen

CAMP HILL, Pa. – From Dec. 2 through 12, Rite Aid will offer discounts on select trivalent flu shots in support of National Influenza Vaccination Week. Flucelvax, a cell based vaccine, will be available for $32.99, and the standard trivalent flu shot for $26.99, a discount of $5. 
 
“According to the Centers for Disease Control and Prevention, flu vaccination coverage from previous years has shown that influenza vaccination activity declines quickly after November,” said Jocelyn Konrad, Rite Aid EVP pharmacy. “National Influenza Week is a great time to reinforce the importance of receiving your flu shot and to encourage our customers who haven’t done so already to visit their local Rite Aid and conveniently get vaccinated against the flu, as it is the best way to protect yourself and others from this potentially serious illness.”
 
Rite Aid’s Vaccine Central, an assessment tool where visitors can complete a personal immunization evaluation, is an additional resource for people to further review immunization recommendations. By visiting Vaccine Central, customers can track their personal immunization history and find other educational resources on immunizations. 
 
Created by the CDC in 2005, National Influenza Vaccination Week is a national observance that was established to highlight the importance of continuing influenza vaccination, as well as fostering greater use of flu vaccine after the holiday season into January and beyond.
 
The CDC recommends a yearly flu vaccine for everyone 6 months of age and older as the first and most important step in protecting against this serious disease. 
 
Rite Aid pharmacists are available to administer vaccinations for 12 other diseases, such as pertussis (whooping cough), shingles and pneumonia, subject to state regulations. 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Camber launches generic Cozaar

BY David Salazar

PISCATAWAY, N.J. — Camber Pharmaceuticals on Tuesday announced that it had launched its portfolio of generic versions of Merck’s Cozaar (losartan potassium) tablets. The drug is indicated to treat high blood pressure. 
 
Camber’s losartan tablets will be available in 25-mg dosage strength — available in 90, 500 and 1,000 count bottles — and 50- and 100-mg dosage strength, both of which are available in bottles of 90 and 1,000. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Express Scripts, Imprimis partner on $1 Daraprim alternative

BY DSN STAFF

ST. LOUIS — Express Scripts announced Wednesday that it would be working with Imprimis Pharmaceuticals to provide a low-cost alternative to Daraprim — a drug meant to treat toxoplasmosis whose price went from $13.50 to $750 overnight when it was acquired by Turing Pharmaceuticals in September.

Imprimis will offer a compounded oral combination of pyrimethamine and leucovorin for $1 per capsule for patients whose benefits are managed by Express Scripts. The companies hope to start processing prescriptions for the formulation as early as this week.

“Leveraging our expertise to improve access and affordability to an important medication is the right thing to do for HIV patients and others who could benefit from a combination of pyrimethamine and leucovorin,” Express Scripts SVP and chief medical officer Dr. Steve Miller said. “We believe we now have an extremely cost-effective way to provide access to a Daraprim alternative. We will share our solution with other payers to make sure all appropriate patients around the country have access to the treatment they need at the lowest possible price.”

Express Scripts said it would work with such organizations as the Infectious Disease Society of America and the HIV Medicine Association to inform providers about the value of the formulation. To prescribe it, they write a patient-specific prescription for the combination of the two drugs to Imprimis, which will then compound it.

“We are pleased to partner with Express Scripts to take positive action to counterbalance companies like Turing and others in order to address the growing drug pricing crisis in America,” Imprimis CEO Mark Baum said. “Like Imprimis, Express Scripts believes in putting patients first and that the excessive drug price increases we have seen over the past few years, particularly for life saving medicines such as Daraprim, deserve our attention.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?